Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,128 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07006493Recruiting
Radiofrequency ablation for obstructive hypertrophic cardiomyopathy
This trial tests a new treatment that uses radiofrequency energy (similar to heat) to shrink the thickened heart muscle blocking blood flow. It is for people with obstructive hypertrophic cardiomyopathy who have symptoms despite medication and are not able or willing to have heart surgery.
Beijing, Beijing MunicipalityAges 18–80 - NCT07011056RecruitingPhase 3
Study of a new drug for diffuse large B-cell lymphoma
This trial tests a new drug called Purinostat Mesylate for people with diffuse large B-cell lymphoma (a type of blood cancer) whose cancer has come back or not responded after at least two prior treatments. It aims to see if the drug can help shrink or control the cancer.
Chengdu, SichuanAges 18 years+ - NCT07011420Recruiting
Testing different prosthetics controls for arm amputees
This trial tests how different numbers and types of muscle signals (myoelectric) affect control of a prosthetic hand and wrist. It aims to find the best setup for people with a below-elbow amputation who have used a myoelectric prosthetic before.
Chicago, IllinoisAges 18 years+ - NCT07012291Recruiting
Blood test for patients on blood thinners
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
Danbury, ConnecticutAges 18–80 - NCT07018648Recruiting
Testing a wearable heart monitor for rhythm problems
This trial tests a chest belt that works with your smartphone to track heart rhythms. It may help if you have or might have an irregular heartbeat.
Olomouc, CzechiaAges 18 years+ - NCT07026240Recruiting
Post-operative monitoring study for gastric cancer
This study monitors people after surgery for gastric cancer. It checks how patients recover and helps doctors learn more about the condition. You can join if you have stomach discomfort and are receiving care at the gastric surgery clinic of this center.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07028021Recruiting
Water turnover study of the Chinese population
This study measures water turnover in healthy Chinese adults using a safe deuterium dilution method. It aims to understand normal body water regulation.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07028554Recruiting
Study of disposable staplers in surgery
This trial is looking at how well disposable endoscopic linear cutting staplers work in various surgeries. It may be an option if you are having open or minimally invasive surgery in general, gynecologic, urologic, or thoracic procedures.
Ningbo, ZhejiangAges 18 years+ - NCT07030998Recruiting
Using smartwatch data to find early signs of infection in kids with cancer
This trial uses an Apple Watch and a smartphone app to track health data and detect early signs of infection in children and teens getting cancer treatment. The goal is to catch problems early so they can be treated quickly.
Parkville, VictoriaAges 5–18 - NCT07031713RecruitingPhase 1
Testing CT1192 cells for lupus that hasn't responded to treatment
This trial tests a new treatment called CT1192, which uses your own immune cells (T-cells) that are modified to target and calm overactive immune cells causing lupus. It is designed for people with moderate to severe lupus that hasn't improved with standard therapies like steroids, immunosuppressants, or biologics.
Wuhan, HubeiAges 18–60 - NCT07036250RecruitingPhase 1/Phase 2
Study of U32 for acute myeloid leukemia
This trial tests a new treatment called U32 for people with acute myeloid leukemia (AML) that has come back or not responded to prior therapy. It aims to see if targeting certain proteins on leukemia cells can help control the disease.
SuzhouAges 2–65 - NCT07036965Recruiting
Comparing two types of ablation catheters for atrial fibrillation
This trial tests two different catheters that use pulsed field energy to treat atrial fibrillation (a heart rhythm problem). It aims to find which one works better for people who need blood thinners but have a high risk of bleeding.
HangzhouAges 118 years+ - NCT07041801RecruitingPhase 1/Phase 2
Stem cell therapy for lupus patients
This trial tests whether a type of stem cell from umbilical cords can help people with systemic lupus erythematosus (an autoimmune disease). It aims to find a new way to reduce lupus symptoms and improve quality of life.
Shenzhen, GuangdongAges 18–65 - NCT07051811Recruiting
Blood vessel treatment for hard-to-control high blood pressure
This trial tests a new device that uses ultrasound to treat nerves in the kidney arteries that may be overactive and raising your blood pressure. It's for people whose blood pressure stays high despite taking at least two medications.
Beijing, Beijing MunicipalityAges 18–75 - NCT07054294Recruiting
Energy use in healthy Chinese children
This trial measures how much energy healthy children in China use every day. It aims to understand energy needs across childhood and could help improve nutrition guidelines.
Shenzhen, GuangdonngAges 7–13 - NCT07057102Recruiting
Gene testing to predict lung cancer treatment response and monitor recurrence
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07057414RecruitingPhase 2
Testing GMDTC for removing excess cadmium
This trial tests an injectable medicine called GMDTC to help remove extra cadmium (a heavy metal) from the body. It is for people with high cadmium levels and decent kidney function, to see if the drug is safe and effective.
Guangzhou, GuangdongAges 18–70 - NCT07059936Recruiting
AI and scans to predict immunotherapy response in liver cancer
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
Wuhan, HubeiAges 18 years+ - NCT07059923Recruiting
Predicting immunotherapy response in lung cancer with AI and radiology
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Wuhan, HubeiAges 18 years+ - NCT07061301Recruiting
Leaving the hospital with insulin: a transition study
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
Valencia, ValenciaAges 18–70 - NCT07064486RecruitingPhase 3
BGM0504 for type 2 diabetes in Indonesia
This study tests a new medicine called BGM0504 for people with type 2 diabetes who are already taking metformin. It may help improve blood sugar control and weight.
Depok, West JavaAges 18–75 - NCT07066202Recruiting
Testing smart tools for safety and independence
This trial tests a set of smart, easy-to-use tools designed to help people with disabilities live more freely and safely. It aims to see if these tools boost your independence at home or in the community.
Milan, ItalyAges 18 years+ - NCT07068438Recruiting
Pulsed electric field for chronic bronchitis
This study tests a new treatment that uses brief electric pulses to clear blocked airways in people with chronic bronchitis. It might help if you have a long-term cough with mucus and standard medicines aren't enough.
Hefei, AnuiAges 35–80 - NCT07074431Recruiting
Comparing two methods for cataract surgery
This trial compares a new high-frequency pulsed vacuum technology to standard cataract surgery (phacoemulsification) for treating cataracts in both eyes. It aims to see which method works better and is safer for people with mild to moderate cataracts.
AmiensAges 18 years+
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,128 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.